GRFS vs OCSL

For growth investors, Oaktree Specialty Lending Corporation (OCSL) is the stronger pick with 60.

9% revenue growth year-over-year, versus 0. 2% for Grifols, S. A. (GRFS). Grifols, S. A. (GRFS) offers the better valuation at 12. 0x trailing P/E (9. 2x forward), making it the more compelling value choice. Analysts rate Grifols, S. A. (GRFS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Grifols, S.

A. (GRFS) is the cheapest at 12. 0x versus Oaktree Specialty Lending Corporation at 31. 3x. On forward P/E, Oaktree Specialty Lending Corporation is actually cheaper at 8. 1x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Oaktree Specialty Lending Corporation (OCSL) delivered a total return of +11.

0%, compared to -52. 8% for Grifols, S. A. (GRFS). Over 10 years, the gap is even starker: OCSL returned +89. 5% versus GRFS's -35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Oaktree Specialty Lending Corporation (OCSL) is the lower-risk stock at 0.

64β versus Grifols, S. A. 's 1. 12β — meaning GRFS is approximately 74% more volatile than OCSL relative to the S&P 500. On balance sheet safety, Oaktree Specialty Lending Corporation (OCSL) carries a lower debt/equity ratio of 101% versus 115% for Grifols, S. A. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Oaktree Specialty Lending Corporation (OCSL) is pulling ahead at 60.

9% versus 0. 2% for Grifols, S. A. (GRFS). On earnings-per-share growth, the picture is similar: Grifols, S. A. grew EPS 147. 8% year-over-year, compared to -45. 8% for Oaktree Specialty Lending Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Oaktree Specialty Lending Corporation (OCSL) is the more profitable company, earning 11.

3% net margin versus 5. 3% for Grifols, S. A. — meaning it keeps 11. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OCSL leads at 50. 4% versus 16. 4% for GRFS. At the gross margin level — before operating expenses — OCSL leads at 87. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Oaktree Specialty Lending Corporation (OCSL) trades at 8.

1x forward P/E versus 9. 2x for Grifols, S. A. — 1. 1x cheaper on a one-year earnings basis.

All stocks in this comparison pay dividends.

Oaktree Specialty Lending Corporation (OCSL) offers the highest yield at 14. 1%, versus 2. 6% for Grifols, S. A. (GRFS).

For long-horizon retirement investors, Oaktree Specialty Lending Corporation (OCSL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

64), 14. 1% yield). Both have compounded well over 10 years (OCSL: +89. 5%, GRFS: -35. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (GRFS (Healthcare) and OCSL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: GRFS is a small-cap deep-value stock; OCSL is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.